Tumor growth model for ductal carcinoma: from in situ phase to stroma invasion by Colin, Thierry et al.
HAL Id: hal-00962163
https://hal.inria.fr/hal-00962163v2
Submitted on 24 Mar 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Tumor growth model for ductal carcinoma: from in situ
phase to stroma invasion
Thierry Colin, Olivier Gallinato, Clair Poignard, Olivier Saut
To cite this version:
Thierry Colin, Olivier Gallinato, Clair Poignard, Olivier Saut. Tumor growth model for ductal car-






































Tumor Growth Model for
Ductal Carcinoma: from
in Situ Phase to Stroma
Invasion




200 avenue de la Vieille Tour
33405 Talence Cedex
Tumor Growth Model for Ductal Carcinoma:
from in Situ Phase to Stroma Invasion
Thierry Colin, Olivier Gallinato, Clair Poignard∗, Olivier Saut
Project-Teams MC2
Research Report n° 8502 — March 2014 — 31 pages
Abstract: We propose a tumor growth model, based on partial differential equations, for
breast ductal carcinoma. In particular, we focus on the transition from the in situ stage to the
invasive phase, under the action of specific enzymes: matrix metalloproteinases (MMPs), that are
produced by cancer cells. Advection equations describe the movement of biological cells, generated
by cancer cell proliferation that exerts pressure on the surrounding tissues. In its early phase,
ductal carcinoma remains confined to the galactophoric duct due to the basement membrane.
However, as soon as MMP enzymes are produced, they are able to degrade the membrane, which
leads to cancer invasion. The specificity of the model lies in the description of these phenomena
and the modeling of the duct membrane degradation, thanks to nonlinear Kedem-Katchalsky type
transmission conditions to describe the pressure.
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Modèle de croissance tumorale pour un carcinome
canalaire : de la phase in situ à l’invasion du stroma
Résumé : On propose un modèle de croissance tumorale, à partir d’équations aux dérivées
partielles, pour le carcinome canalaire du sein. On se concentre en particulier sur la transition
entre le stade in situ et la phase invasive de la croissance, sous l’influence d’enzymes spécifiques :
les métalloprotéinases matricielles (MMP) qui sont produites par les cellules cancéreuses. On
utilise des équations d’advection pour décrire le mouvement des cellules biologiques, engendré
par la prolifération des cellules cancéreuses qui crée une pression dans les tissus avoisinants.
Pendant sa première phase de développement, le carcinome canalaire reste confiné dans le canal
galactophore du fait de la membrane basale. Mais dès que les enzymes MMP sont produites, elles
dégradent la membrane, ce qui conduit à l’invasion cancéreuse. La spécificité du modèle réside
dans la description de ces phénomènes et dans la modélisation de la dégradation de la membrane
par l’utilisation de conditions de transmission non-linéaires, du type Kedem-Katchalsky, pour
décrire la pression.
Mots-clés : modèle de croissance tumorale, équations d’advection non-linéaires, conditions de
Kedem-Katchalsky, cancer du sein, métalloprotéinases
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1 Introduction
Ductal carcinomas, that occur in galactophoric ducts, are among the most common breast can-
cers. Under certain circumstances, these cancers may become invasive and agressive by crossing
the duct membrane. In this paper, we propose a tumor growth model for two types of ductal
carcinomas: the ductal carcinoma in situ (DCIS) and the invasive ductal carcinoma (IDC). DCIS
remains confined to the duct due to the duct membrane which yields a barrier. But if some can-
cer cells produce enzymes called MMPs which degrade the membrane, DCIS then turns into an
IDC, which is much more agressive.
We propose a continuous model based on partial differential equations, which describe the
tumor growth by considering the cell densities, in the same way as in [1, 2, 3]. The tumor growth
is driven by an advection equation which takes into account the fact that cancer cell proliferation
generates a pressure that pushes the healthy tissue. The new feature of our model lies in the
modeling of the duct membrane, which separates the lumen from the breast tissue and which is
degraded by the MMPs.
1.1 Biological background
Breast consists essentially of galactophoric ducts, lobes and fatty tissue [4]. A scheme of breast
is given at Fig. 1. The ducts are surrounded by a connective tissue, the stroma, and consist of a
basement membrane and an epithelium surrounding the central opening in which flows the lumen
(Fig. 1, A). Ductal carcinoma derives from an epithelial cell inside the duct. It is a dysfunction
Figure 1: Simplified anatomy of the breast and different stages of the evolution of a duct carcinoma.
of the epithelial cells that proliferate uncontrollably. Its origin and subsequent developments
combine genetic and environmental factors, including many underlying mechanisms, which still
Inria
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remain poorly understood. The development of a precancerous lesion in epithelium, as hyper-
plasia (Fig. 1, B and C), increases the risk of abnormalities. In particular, the disruption of
interactions with the membrane may cause an accumulation of abnormal events in epithelial tis-
sue, leading to cancer initiation and genetic instability [5, 6]. Among the consequences of genetic
mutations, the increase in mitosis rate, the loss of cell polarity, the breakage of adhesion junc-
tions and the ability to evade apoptosis lead to uncontrolled growth of the tissue and to tumor
formation inside the duct. As long as tumor growth remains confined to the duct, carcinoma
is called in situ (Fig. 1, D). The key point is then to determine whether or not the tumor will
pass through the membrane (Fig. 1, E and F), since it makes the difference between a low-grade
cancer, rather non-aggressive, and a high-grade cancer, invasive, progressing to a vascular stage
and leading to metastasis and invasion of the body. MMP enzymes have the property to degrade
the extracellular matrix (ECM) of biological tissues, enabling to reshape them under normal
circumstances. In the case of ductal carcinomas, the production of MMP enzymes leads to the
degradation of the basement membrane ECM. The membrane becomes porous, which makes
possible the cancer cell invasion. The issue of MMP production, which is complex and not well
understood yet, is crucial in this study.
1.2 Outline and positionning
The aim of the paper is to build a model that can reproduce qualitatively the different configu-
rations observed in the medical experiments and the biopsy results. In Section 2, we derive our
new model, based on the biology of ductal carcinoma. New developments, compared to other
existing tumor growth models, can be classified into two types:
1. Specific aspects of the model as a model for breast cancer:
• the mechanics related to the duct are taken into account,
• the vascularization is located outside the duct, therefore the growth phase in situ is
an avascular phase,
• the nutrients diffusion is artificially forced within the duct, which avoids introducing
a nonlinear diffusion to obtain realistic rates of nutrients.
2. Non-specific aspects:
• the pressure is taken into account in the proliferation rate, as some studies show that
it tends to limit cancer cell proliferation [7, 8],
• the very low thickness of the basement membrane led us to model it as an interface
with jump conditions to link the outer and inner media thanks to Kedem-Katchalsky
type conditions.
Section 3 is devoted to 2D numerical results from single-cell or multi-cell models, depending on
whether the cancer is initiated from one single cell or more, inside the duct. The results show the
membrane degradation under the action of MMPs, and the progression of an invasive carcinoma
through the membrane. However, whatever the fit of the parameters, the results are not very
realistic, too homogeneous and symmetrical (see Fig. 18 at Section 4). The model is then refined
in Section 4 to compare some possible causes of heterogeneity:
• introduction of a mutation on certain cancer cells, which causes the MMP production,
resulting in an anisotropic tumor invasion,
• modeling the role of cells of the microenvironment that produce MMPs or TNFs (tumor
necrosis factors), with satisfactory results in terms of tumor heterogeneity.
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In particular, the consideration of the microenvironment influence on the MMP production leads
to one of the most significant result of the study, given by Fig. 2: numerical results (Fig. 2a)
show the invasion of the breast tissue due to the membrane disruption, and are qualitatively
similar to biopsies (Fig. 2b).
(a) IDC simulation (b) Biopsy [9]
Figure 2: Main result : qualitative comparison of our simulation with biopsy.
Finally, we conclude by pointing out the pros and the cons of our modeling, and we raise
some questions that are still opened in breast cancer modeling.
2 Tumor growth model
The structure of the model is outlined in Fig. 3. For the sake of clarity, we subdivide our model












Figure 3: Schematic diagram of the model structure.
describes the general movement of cell species caused by the pressure due to cell proliferation.
The specificity lies in the modeling of the very thin membrane as an interface across which
Kedem-Katchalsky type conditions are imposed to describe the pressure jump. Submodel 2, given
at Subsection 2.3, describes the action of MMP enzymes, leading to cell invasion, which is crucial
in this study. Finally, submodel 3, dealing with nutrients, will be discussed in Subsection 2.4.
It considers that the supply of nutrients comes from the membrane vasculature and from the
neo-vasculature resulting from the angiogenesis.
2.1 Notations and hypotheses
We focus on four cell species: at the initial time, healthy cells are outside the duct (stroma),
the lumen and the tumoral tissues are inside. Initially there is no necrotic tissue. We denote
Inria
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by P , N , S and L the respective fractions of proliferating, necrotic, healthy and luminal cell
populations, such that, in the whole domain we have
P + N + S + L = 1 ∀t, x. (1)
These variables depend on the time t and the position x = (x, y). The total cell density, denoted
by đ0, is assumed to be constant in time and in the whole domain. We assume that cellular species
behave like an incompressible, passive and porous fluid, driven by a homogeneous movement.
The healthy tissue and the lumen cell activity are neglected. The basement membrane, whose
porosity (or permeability) is very low when it is not degraded, is an insulating barrier between
the interior of the duct and the breast tissue. We denote by Ω the considered domain composed





Figure 4: Simple geometry: Ω denotes the whole domain, Ω0 the duct, Ω1 the stroma, Γ the duct
membrane with zero thickness.
2.2 Cell movement and pressure equations
The main steps of tumor growth are outlined in Fig. 5: after cancer initiation, tumor cells either
turn into necrotic cells or proliferate, depending on the nutrient concentration. The growth of
volume due to cellular division induces the movement of the whole tissue.
2.2.1 Advection
We assume that the cells move according to the same velocity field v, due to the pressure
generated by the proliferation. Applying the principle of mass balance, we obtain that the
general movement is governed by the following advection equations that hold in Ω:
∂tP + ∇ · (vP ) = (αP − αN )P, (2a)
∂tN + ∇ · (vN) = αN P, (2b)
∂tS + ∇ · (vS) = 0, (2c)
∂tL + ∇ · (vL) = 0, (2d)
where αP and αN denote the rates of proliferation and necrosis, respectively. The necrosis rate
is a transition rate between proliferating and necrotic cells. The velocity field v arises from
the division of proliferating tumor cells, at the rate αP , which are responsible for the volume
RR n° 8502


























Figure 5: Schematic diagram of submodel 1.
growth. By summing the equations (2a)–(2d) and using the saturation condition (1), we obtain
the divergence of the velocity in Ω:
∇ · v = αP P. (3)
2.2.2 Proliferation and necrosis rates
The proliferation and necrosis rates are driven by genetic internal factors and by environmental
factors: the nutrient concentration Θ and the pressure Π. Actually, among the environmental
influences, the pressure exerted on tumor cells has a significant impact in reducing their rate of
proliferation. This intuitive idea seems to be supported by the ongoing work about the role of
the microenvironment on tumor growth, led by the teams of D.A. Fletcher and M.J. Bissell [7, 8].
For the sake of simplicity, we shall generically call hypoxia the lack of nutrients. We therefore
express the proliferation and necrosis rates by:
αP = α fP (4a)
αN = α fN (4b)
where α is a generic rate which is weighted by the functions fP and fN . The functions fP and
fN are dimensionless weight functions for proliferating and necrosis rates, respectively. They
contain the genetic factors, the pressure, the nutrient influences, and are given by
fP (Θ, Π) = αG
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• Πmax is the maximal pressure that cancer cells can withstand before stopping their mitoses.
ΘH and ΘN are the hypoxia and necrosis thresholds for nutrient concentration Θ. We
impose
0 < ΘN < ΘH ,
such that for Θ smaller than ΘN cancer cells P turn into necrotic cells N , between ΘN
and ΘH the cells P do not proliferate, but are not necrotic: they are in a quiescent phase.
Above ΘH the proliferating cells P proliferate and the tumor grows.
• ΛP and ΛN are strictly positive constants, homogeneous to the inverse of a concentration.
They give the slopes of the curves representing fP and fN in the neighborhood of the
thresholds ΘH and ΘN ,
• αG is a weight function whose value is between 0 and 1. It represents the quantitative
influence of oncogenic factors, such as the overexpression of estrogen receptors or other
growth factor receptors like HER-2 [10, 11]. In this study, for the sake of simplicity, αG is
supposed to be homogeneous and constant.
2.2.3 Pressure equation
Cell division generates a pressure in the tissue and thus the cellular movement. Darcy law













Figure 6: Γ is considered as an interface.
very low permeability (Fig. 6), we link the outer and inner media thanks to Kedem-Katchalsky
conditions [13, 14], which are an asymptotic version of the conditions used in [1]:
− ∇ · (k∇Π) = αP P in R
+ × (Ω0 ∪ Ω1), (6a)
[k∂nΠ] = 0, (6b)
κm[Π] = k∂nΠ|Γ+ , (6c)
Π|∂Ω = 0, (6d)
where
• Γ denotes the membrane,
• brackets [·]denote the jump from Ω0 to Ω1 across the membrane Γ,
RR n° 8502
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• n is the normal to Γ,
• κm represents the surface membrane permeability, homogeneous to the membrane perme-
ability divided by its thickness.
The medium permeability is denoted by k and as cellular species have different permeabilities,
we set on Ω \ Γ:
k = kLL + kSS + kN N + kP P.
Actually we shall call permeability of the medium, by abuse of language, the ratio between the
permeability and the viscosity, where the viscosity is assumed to be constant.
The homogeneous condition imposed on the boundary is a kind of transparent boundary
condition: it reflects the hypothesis that tumor growth is negligible compared to the volume of
tissues that make up the breast. Tumor pushes healthy tissue outside the computational domain
without feedback on the internal pressure.
2.3 Role of MMPs
In our model, P cells are supposed to produce MMPs which are locally diffused. Then, they






















Figure 7: Schematic diagram of submodel 2.
2.3.1 Action on membrane permeability
The pressure accumulated in the tumor that was previously confined to the duct, tends to limit
and block the proliferation. But as soon as the membrane is damaged by the action of MMPs, the
pressure is released, the cell divisions restart and tumor cells can cross the membrane to invade
healthy tissue. MMPs make the basement membrane porous and can break it, by degrading
the extracellular matrix, that is to say by breaking cellular adhesions. The surface membrane
permeability as a function of MMP concentration is therefore essential in the model. Actually,
the medium permeability reflects the degree of cell adhesion. While the membrane is intact, the
membrane permeability is denoted by κ0 which is very small. Then, relation (6c) shows that the
pressure problem tends to a Neumann problem: cells cannot cross the membrane. Conversely,
Inria
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a high permeability means that the junctions are fewer and the tissue is more permeable: re-
lation (6c) then expresses the fact that the pressure flux is non-zero across the membrane, as
well as the velocity (according to Darcy law). Thus, the action of MMPs, whose concentration
is denoted by M , can be modeled by modulating the membrane permeability: tumor remains
confined inside the duct if permeability tends to zero and invades if it is larger. We therefore set:
κm(t, x) = κ
0 + (κmax − κ0) sup
s∈[0,t]
(





• κ0 denotes the very low membrane permeability when it is intact,
• κmax denotes the membrane permeability when it is completely degraded,
• ΛM is strictly positive, homogeneous to the inverse of a concentration, and gives the slope
of the curve,
• Mth is the enzymatic threshold from which the MMPs start to degrade the membrane.
We neglect the regeneration of the basement membrane. In the expression (7), the supremum in
time therefore reflects the irreversibility of the degradation phenomenon.
2.3.2 Action on other tissues permeability
It is obvious that if MMPs act on the membrane extracellular matrix, they have a similar effect
on other surrounding tissues. By modeling the ECM degradation of tumor tissue P and tissue
S (of permeability kP and kS respectively), we simulate a greater mobility of cancer cells and
a more rapid increase in the stroma, consistent with biological processes. kmax denotes the
maximum permeability of tissues P and S, and a couple (KX , MthX) is assigned for each tissue
X (X stands for P or S) whose permeability is denoted by kX :
kX(t, x) = k
0
X + (k
max − k0X) sup
s∈[0,t]
(




where ΛX is homogeneous to the inverse of a concentration. Finally, MMPs have no influence
either on the necrotic tissue N or on lumen L. The first one is dead tissue and is subject to
calcification that we consider as immediate and relatively low permeability. The lumen is a liquid
whose permeability is assumed to be close to that of water, higher than kmax.
2.3.3 Basic model of production and diffusion of MMPs
The key issue is the production of MMPs. This question has been extensively studied in biological
literature but remains still unclear because of its complexity [15, 16, 17]. As a first step, we assume
that MMPs are just produced by the proliferating cells P at the rate αM and from the carcinoma
initiation. Then, they diffuse through the tissues and are partially inhibited at rate µ by another
type of protein: the TIMPs (Tissue Inhibitors of MetalloProteinase). To simplify, we consider
that the rate of production αM and the rate of degradation µ are constant. A reaction-diffusion
equation is therefore used:
∂tM − ∇ · (DM ∇M) = αM P đ0 − µM, (8a)
M |t=0 = 0, (8b)
M |∂Ω = 0. (8c)
RR n° 8502
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We assume that MMPs diffuse locally and do not reach the boundary, hence the homogeneous
boundary conditions. The evolution equation reflects the fact that although the biological phe-
nomenon of diffusion is faster than the advection on a small spatial scale (a few nanometers), it
is much slower at larger scales (a few millimeters) [18]. To simulate a local action, we assume
that the diffusion coefficient DM has a higher value in the region where the molecule is produced.
We therefore define the MMPs diffusion coefficient DM by
DM = D
prod
M P + D
diff
M (1 − P ),
0 < DdiffM < D
prod
M < ∞.
2.4 Nutrients and angiogenesis
Cells need nutrients, in particular for mitosis. As a result, cancer cells require more nutrients than
normal cells. Nutrients, whose concentration is denoted by Θ, are provided by the membrane












































Figure 8: Schematic diagram of submodel 3.
2.4.1 Avascular stage
The vascularization of the membrane is the only source of nutrients at the avascular stage of
tumor growth. We assume that this is an average vascularization on Γ, providing at each point of
Γ a constant nutrient concentration equal to Θmax at the constant rate αθ. It is further assumed
that the capillaries are damaged at a constant rate β, when tumor cells P invade and crush them.
Inria
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We thus define this source of nutrients by
Smemb = (αθ − β P ) Θ
max
1Γ. (9)
where 1 denotes the indicator function.
2.4.2 Angiogenesis
The second source of nutrients is angiogenesis, at the stage of vascular growth. We use a model
of angiogenesis similar to the one of F. Billy [19]. When the tumor infiltrates outside the duct,
it needs more and more nutrients as the number of proliferating cells grows. Then, the hypoxic
cells react by producing angiogenic factors, of concentration denoted by ξ, which are diffused:
− ∇ · (Dξ∇ξ) = αξfξP đ0, on Ω, (10a)
ξ|∂Ω = 0. (10b)
The production rate of angiogenic factors, denoted by αξ, is weighted by the function fξ that
contains the hypoxic condition:
fξ(Θ) =
1 − tanh [Λξ(Θ − ΘH)(Θ − ΘN )]
2
(11)
where the parameter Λξ is homogeneous to the square of a concentration. The signal ξ implies
the formation of new blood vessels, composed of endothelial cells, according to the well-known
biological process of chemotaxis. Endothelial cells are a part of S cells. Their proportion relative
to the cells S is denoted by ν. They are provided at the rate αν by the initial blood network
R0, which is assumed to be composed only of endothelial cells. They are then transported in the
direction of the gradient of the angiogenic factors, leading to the formation of a new vasculature
R. ν is thus driven by the following equations:
∂tν + ∇ · (χ ν ∇ξ) = αν1R0 + (αν − β P ) ν (1 − ν)1R, on Ω, (12a)
ν|∂Ω = 0 (12b)
ν|R0 = 1 (12c)
ν|t=0 = 0, on Ω r R0. (12d)
where
R|t=0 = Ø, R = {(t, x) : ν(t, x) ≥ νmin} .
The new vasculature R also provides endothelial cells at the rate αν , and is subject to degradation
by P cells at the rate β. The term (1 − ν) is a term of saturation to prevent overcrowding. The
chemotaxis coefficient χ is built so that the endothelial cells are easily transported in lumen and
healthy tissue and do not progress in the tumor tissue and through the basement membrane:
χ = χLL + χSS.
Finally, considering that the new vascularization diffuses a concentration of nutrients denoted
by Θmaxν at the constant rate αθν , the second source of nutrients is given by
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2.4.3 Diffusion
The diffusion of nutrients from the two sources Smemb and Sangio, is assumed to be instantaneous
and is described by a static diffusion equation:
− ∇ · (Dθ∇Θ) = Sangio + Smemb − φPΘ, on Ω, (14a)
Θ|∂Ω = 0. (14b)
P cells are supposed to consume nutrients at rate φ = λαP , in proportion to their rate of division.
Dθ denotes the diffusion coefficient.
2.4.4 Correction
Inside the duct, at the avascular stage, the diffusion radius should be of the order of a few hundred
microns for a duct diameter of 1 millimeter. It is therefore decided to truncate artificially the
diffusion of nutrients in the center of the duct, otherwise the equation (14a) gives a uniform
distribution of nutrients. Truncation avoids introducing a nonlinear diffusion coefficient, which
would complicate the numerical resolution. Thereby, we bring an explicit correction to Θ by





), if δ ≥ l,
Θ, otherwise,
(15)
where c is a positive constant, R the duct radius, l the diffusion radius from the membrane
towards the center of the duct and δ the distance to the membrane inside the duct (estimated
using a level set function).
3 Numerical results
3.1 Implementation
The following 2D-simulations of DCIS and IDC are implemented in C++ from a finite-volume
discretization on cartesian grid. For the sake of simplicity, the duct is assumed to be cylindrical















(c) 2D cross section
Figure 9: Domain Ω for simulations.
In this paper, results are mostly presented in cross section, in order to be compared with some
medical biopsies. Simulations are carried out on a 100 × 100 mesh. Significant parameters used
in the simulations are given in Table 1. They are empirically determined to reproduce biological
observations. Note that the rate of MMP production αM is vanishing for DCIS simulations and
equal to 1000 for IDC simulations.
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α 8 DprodM 1
αM 0 - 1000 D
diff
M 0.1
µ 2 Dθ 0.1
αθ 1 Dξ 2
αθν 1 Chemotaxis coefficients
β 0.2 χL 1
αξ 10 χS 1
αν 1 Lengths
Concentration thresholds l 0.05
ΘH 3 R 20
ΘN 2.5 Weight function coefficients
Mth 70 ΛP 30
MthS 50 ΛN 30
MthP 40 ΛM 1
Θmax 100 KS 30
Θmaxν 100 KP 30
Permeabilities Λξ 30
kL 2 Other parameters
kN 0.05 αG 0.8
kmax 0.5 νmin 0.1
k0S 0.1 λ 0.2




Table 1: Simulation parameters. Values are empirically determined.
3.2 Initial setup
3.2.1 Cancer initiation
Some images raise questions about the starting point of a tumor. Fig. 10 seems to suggest
that the tumor does not necessarily start from only one defective cell but from many. As the
bibliographic sources are unclear on the topic, we assume that a tumor may be derived from one
or more cells. In the case of a single initial cancer cell, we set P 0 = 1 in a small area supported by
the membrane at the bottom of the duct. In the case with many initial cancer cells, we consider
that they have appeared along the epithelial tissue, and they are initially randomly distributed in
space. We assume that along the duct membrane, on the inner part, one fifth of the cell density
is defective. For each simulation, we will specify if it is a ’single-cell simulation’ or a ’multi-cell
simulation’.
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Figure 10: Micropapillary tumor in situ. Emergence of several cancerous foci. Biopsy from [20].
3.2.2 Healthy tissue and nutrients
Initially, for all runs, we set
N0 = 0, in Ω, S0 = 1, in Ω1, L
0 = 1 − P 0, in Ω0.
The pressure is assumed to be zero and nutrient initial conditions are set such that
f0P = αG, f
0
N = 0.
Moreover, R0, the initial blood network for angiogenesis, is localized far away from the duct.
3.3 Preliminary results: nutrient influence for a DCIS
We first consider a carcinoma in situ, without MMPs, by setting αM = 0. As expected, if
nutrient conditions are set to be sufficient (Θmax = 1000 for example) the tumor fills the duct
(solid carcinoma). Fig. 11, obtained by modulating the source Θmax (single-cell simulation),
shows the formation of a quiescent core, no longer proliferating, when the nutrient concentration
is below the hypoxia threshold. In Fig. 11b, the nutrient concentration at the center of the tumor
(a) Θmax = 100, some cells
become quiescent (encircled a-
rea).
(b) Θmax = 50, a necrotic core
is formed in the center (enclosed
area)
Figure 11: Nutrient influence: quiescent cells are in light blue and necrosis in dark blue (t=11).
is below the threshold of necrosis, resulting in cell death. There is a difference in growth rate
due to the wider area of quiescence and necrosis in Fig. 11b. Necrosis can occur in large ducts
in the center of which the nutrient concentration is low. But it can also appear in ducts of all
sizes, depending on the growth rate of the tumor. The quicker the cells proliferate, the more
nutrients they need and the more they deprive their counterparts at the center of the tumor,
resulting in necrosis formation. Then, the size of the necrotic core gives an indication of the
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aggressiveness of the cancer. This kind of tumor is called comedo-carcinoma (Fig.12, multi-cell
simulation, Θmax = 50, t=10), a type of breast cancer often high-graded, associated with a poor
diagnosis.
(a) Necrosis by simulating hy-
poxia
(b) Tumor with necrosis [21]
Figure 12: Tumors with a necrotic center.
3.4 The limitation of cross-sectional 2D simulations
In the cross-sectional 2D-simulations, L cells cannot be evacuated by the tumor in the transverse
direction: they are enclosed by the membrane and they cannot move. Therefore, the saturation
condition (1) is used to compute rather than the advection equation (2d):
L = 1 − (P + S + N).
Yet the problem is not resolved: the pressure cannot normally be removed from the duct. Actu-
ally, the homogeneous Dirichlet condition (relation (6d)) plays the role of a transparent condition
on the boundary ∂Ω, which makes it possible for the pressure to be evacuated from the compu-
tation domain. In contrast to the case in longitudinal section, the interior media in cross section
is not connected to the boundary. Consequently, the pressure is not evacuated and builds up
in the duct, leading to the proliferation rate decrease. The result is a difference in growth rate
between the transverse and longitudinal sections (Fig. 13, single-cell simulation). Moreover, in
the case of a tumor derived from several cancer cells (Fig. 14), the excessive pressure causes an
artificial competition between them. The tumor foci, in the area where they are more numerous,
create a stronger pressure gradient. Consequently, the velocity field is directed towards the area
where the foci are the fewer. These seem to shrink and disappear (Fig. 14b). In fact, tumor cells
are dispersed within the lumen, which can be checked by changing the scale of observation.
We overcome this difficulty by artificially decreasing the pressure accumulated in the duct
according to an exponential law:






where δ is the distance to the membrane, inside the duct, and R is the duct radius. In the
remainder of the paper, the corrected pressure Πcorr will be denoted by Π.
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Figure 13: Difference of growth between sections: with the same parameters and at the same time
(t = 6), the tumor fills the duct in longitudinal section, but not in cross section where an area consisting
only of lumen is observed (white area).
Figure 14: Some of the tumor foci retract (t = 7 and t = 10).
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3.5 Simulation of tumor invasion
We assume that P cells produce MMPs, by setting αM = 1000. The results in Fig. 15 (single-cell
simulation) show the transition from the in situ stage to invasion of a carcinoma, starting from
a single initial cancer cell. It can be seen in Fig. 15b and Fig. 15c that infiltration logically
(a) t = 7 (b) t = 8 (c) t = 9 (d) t = 9
Figure 15: Evolution of an invasive carcinoma.
starts at the bottom, where the original tumor was. With the same parameters, the simulation
in longitudinal section (Fig. 15d) shows the length of duct affected by membrane degradation
and tumor invasion. Taking angiogenesis into account, we obtain results from the complete
model with the multi-cell simulation given by Fig. 16. In addition to growth and tumor invasion,
(a) t = 5 (b) t = 7 (c) t = 10 (d) t = 12
Figure 16: Invasive carcinoma with angiogenesis (α = 5 and Θmax = 200). Some blood vessels resulting
from angiogenesis are indicated by arrowheads.
Fig. 16 shows the formation of a central necrosis (due to selected nutrient conditions) and the
outbreak of the angiogenesis that will allow the tumor to continue growing in healthy tissue.
In previous results, carcinoma completely degrades the membrane but we can also simulate a
micro-infiltrating carcinoma. According to [23], membrane damage is multifactorial and is not
limited only to the enzymatic action: we should also consider that some parts of the membrane
are weaker than others. We decided to simulate a more sensitive area by modulating the slope
coefficient ΛM in expression (7) of the membrane permeability. By assigning a lower value on
a given area of the membrane (ΛM = 0.2 on this area, 2 elsewhere), MMPs act faster and
degradation only concerns that area. Simulation, as shown in Fig. 17 (multi-cell simulation),
then yields a micro-invasive tumor: the membrane degradation and invasion are highly localized.
4 Different ways for describing heterogeneous tumors
Although the model is capable of reproducing the behavior of a carcinoma that infiltrates through
the membrane, it remains relatively unsatisfactory when compared with biomedical results. In
particular, if the carcinoma has filled out the duct, the entire membrane is rapidly degraded,
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(a) Simulation (b) Biopsy[22]
Figure 17: Comparison of microinvasion between biopsy and simulation with the parameter αM = 600
at t = 8.
due to a homogeneous distribution of tumor cells and therefore of MMPs they produce. Thus,
despite random initial data, the tumor growth is still too uniform (Fig. 18a vs. Fig. 18b).
Obviously, a more irregular duct shape as well as stroma anisotropy could partially explain the
Figure 18: Invasive tumors (biopsy from [24]). The simulation gives a too symmetrical tumor.
tumor asymmetry. But we decided to overcome the lack of heterogeneity by first considering the
effect of a genetic mutation within the tumor, and then the influence of the microenvironment
on the production of MMPs and TNFs. In all cases, we obtain a greater inhomogeneity and more
realistic results.
4.1 Influence of genetic mutations of tumor cells
It is well known that genetic factors are critical in tumor initiation and progression. As cancer
is the result of genetic mutations that can be seen as random in space, a tumor is usually
inhomogeneous in terms of growth and substances which it produces. We assumed in previous
section that each cell produced MMPs from the initial time. We now consider that a random
mutation is occuring in a few selected cells that makes them produce MMPs (Fig. 19). A genetic
mutation means that a cell acquires a specific property which is cloned during cell division.
It requires the definition of new species for each mutation. We then introduce two species of
proliferative cells, P1 and P2. MMPs are only produced by P2. They satisfy the same advection
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Figure 19: Genetic influence on MMP production.
equation (2a) than P :
∂tP1 + ∇ · (vP1) = (αP − αN )P1, (16a)
∂tP2 + ∇ · (vP2) = (αP − αN )P2, (16b)
P = P1 + P2, (16c)
and relation (8a) becomes
∂tM − ∇ · (DM ∇M) = αM P2 đ0 − µM. (16d)
We assume that the mutation has occured before the initial time of simulations. We perform a
multi-cell simulation, in which P 01 and P
0
2 are randomly distributed such that:
P 0 = P 01 + P
0
2 ,
P 01 = 0.8 P
0, P 02 = 0.2 P
0
As the production of MMP is quantitatively changed, we choose specific values for the MMP




Table 2: Changes in the MMP thresholds.
homogeneous (Fig. 20) and we obtain some less symmetrical and more realistic tumors. We could
consider that genetic mutations occur later and obtain the same kind of results. Obviously, it is
possible to introduce some other genetic mutations. For example, some onco-genetic mutations
imply overexpression of cell receptors like HER-2 that, when activated, increase the mitosis rate.
This phenomenon has already been modeled [11] and leads to a rate αG becoming variable in
space and time, in relation (5a). Then, the proliferation rate would be inhomogeneous and could
also lead to various shapes of tumor. What can be retained is that different genetic mutations
can be simulated and give more realistic results, with inhomogeneities in the growth and shape
of the tumor.
4.2 Influence of the microenvironment on production of MMPs
However, genetic factors are not the only ones involved in cancer progression. More and more bi-
ological studies underline that the microenvironnement is also essential. We focus on the impact
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Figure 20: Invasive carcinoma with two populations of proliferating cells. P 1 cells are in blue. P 2
cells, in red, produce MMPs (α = 5).
of the microenvironment on the production of MMPs, which leads us to improve and complexify











Figure 21: Schematic diagram of model improvements.
modeled [23]. Some studies mention the role played by cells of epithelial tissue (myoepithelial
cells) and stromal cells (fibroblasts, macrophages of the immune system, etc.) in MMP produc-
tion [25, 26, 27, 28]. In response to a signal from the tumor, stromal cells migrate towards the
duct and produce MMPs as inactive proenzymes. These are then activated by forming complexes
with MMPs produced by tumor cells (Fig. 22).
To model these processes simply, some stromal cells S are randomly labeled as fibroblasts
denoted by S2, which avoids introducing a new population that would migrate to the tumor: the
important point is that these cells can produce MMPs. Other stroma cells are denoted by S1.
Then, proliferative cells diffuse a chemical signal, of concentration Z, to activate the proenzymes
(Fig. 23). The local action of the signal is simulated with the same diffusion coefficient than for
MMPs. Actually, we assume that the MMP production starts only if the signal concentration
reach a certain threshold Zs. We therefore set:
∂tS1 + ∇ · (vS1) = 0, (17a)
∂tS2 + ∇ · (vS2) = 0, (17b)
S = S1 + S2. (17c)
Relationship (8a) is replaced by
∂tM − ∇ · (DM ∇M) = γS2 đ0 − µM, (17d)
∂tZ − ∇ · (DM ∇Z) = αzP đ0 − µZ, (17e)
Z|t=0 = 0, (17f)
Inria
Tumor Growth Model for Ductal Carcinoma: from in Situ Phase to Stroma Invasion 23

























Figure 23: Schematic diagram of MMP production, considering microenvironment.
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and Λz is homogeneous to the inverse of a concentration. We give the value of the new parameters







Table 3: New parameters and changes in the MMP thresholds for a model that takes the microenvi-
ronment into account.
Regarding the initial conditions, S2 cells are useful only in a neighborhood of the duct and
they are randomly distributed such that, in this neighborhood:
S0 = S01 + S
0
2 ,
S01 = 0.9 S
0 S02 = 0.1 S
0.
The results in Fig. 24 (multi-cell simulation) show a more local breaking point in the membrane
than previously (Fig. 24a). This more localized gap is due to the random distribution of stromal
cells that produce MMPs. Before the membrane is further deteriorated, the tumor starts to come
(a) t = 11 (b) t = 12 (c) t = 13 (d) Biopsy [9]
Figure 24: Improved model simulating the evolution of an invasive carcinoma (α = 5).
out and invade healthy tissue, brimming over the duct. The resulting tumor is asymmetrical and
an analogy is observed between tumor shapes in Fig. 24c and Fig. 24d. However, it should be
noted that Fig. 24d does not exactly represent an invasive ductal carcinoma, but its metastases
that created a secondary focus in a lymph node, which in turn became invasive.
4.3 TNF action
In the same vein, we could take another microenvironmental influence into acount: the TNF
action on necrosis core (Fig. 25). The lack of nutrient is not the only responsible for the develop-
ment of a necrotic core: the tumor necrosis factors (TNFs) seem to be involved with conflicting
effects [29, 30]. It is a chemical secreted by immune cells that infiltrated the tumor and that cause
cell death. TNFs could also play a role in promoting cancer: initiation, proliferation of malignant
cells, angiogenesis and metastases production. Motivated by the idea of modeling more realistic
necroses, larger and with an irregular shape (Fig. 26c), we decide to take the TNF actions into
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Figure 25: Schematic diagram of TNF production and action on necrosis and proliferation rates.
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account. TNFs are supposed to be produced and diffused by infiltrating macrophages, denoted
P ′, which are chosen among P cells, randomly in space and time,
−∇ · (Dτ ∇τ) = ατ P
′ đ0, (18)
where τ denotes the TNF concentration with τ0 = 0.
The action of TNF on the rate of necrosis αN is introduced in the weight function fN and is
assumed to be described by equation (19) instead of equation (5b):
fN = 1 −
1
4
[1 + tanh (ΛN (Θ − ΘN ))] · [1 − tanh (Λτ (τ − τth))] , (19)
where Λτ is homogeneous to the inverse of a concentration. For a given concentration of nu-
trients, the rate of necrosis increases if the TNF concentration exceeds a certain threshold τth.
The simulations reveal a more extensive and irregular necrosis (Fig. 26b) than if only hypoxia
(a) ατ = 0 (b) ατ = 1000 (c) Comedo-carcinoma from [9]
Figure 26: Simulation of the TNF effect on tumor necrosis (t = 11, Λτ = 8, Dτ = 2, τth = 0.5).
is involved (Fig. 26a). The wider necrosis is due to the increase in necrosis rate, and its ir-
regularity to the random distribution of macrophages. Introducing the action of TNFs in the
calculation of the weight function fP of the proliferation rate (equation (5a)), in the same way
as in equation (19), we could also simulate a faster growth under the influence of TNFs, as they
are supposed to promote tumor cells proliferation. Once again, despite a very partial modeling
of biological processes involved, the results seem more realistic (Fig. 26b and Fig. 26c) when the
microenvironment is taken into account.
5 Conclusion
The aim of the study was to model the transition of a breast cancer between its intraductal
phase and the invasive stage, by accounting for the action of MMP enzymes. A continuous
model of tumor growth was developed from advection equations. The use of Darcy law has made
it possible to describe the movement of cell species, depending on the pressure generated by the
division of tumor cells. The very low thickness of the membrane was taken into account by using
a Kedem-Katchalsky model: the membrane is considered as an interface through which there is a
pressure jump. The issue of cross section in 2D-simulations was solved specifically by the addition
of an explicit correction to the pressure inside the duct. At this stage, the simulations yielded
the growth of a tumor inside a galactophoric duct. Then, the role of MMPs has been included
in order to model the membrane degradation. MMPs are the cornerstone in the transition
from an intraductal carcinoma to the invasion stage. Considering that the permeability of the
medium simulates correctly the degree of cell adhesion within tissues, the process of membrane
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degradation was described by the permeability, which is a function of enzyme concentration. The
simulations highlighted the degradation of the membrane, the spread of malignant cells outside
the duct and the tumor invasion.
However, despite adding environmental conditions such as nutrient diffusion and angiogenesis,
the model remained rather inaccurate by assuming that MMPs was produced by tumor cells in
a homogeneous way: the obtained tumors were quite regular and symmetrical, much different
from those observed in the few available biomedical results. Then, the model was enriched in
the purpose of modeling more complex processes involved in tumor growth: taking some genetic
factors into account first, and secondly some influences of the microenvironment, has led us to
more satisfactory results, one of which is given by Fig. 24. Maybe another specific model could
lead to the same kind of result. But it should be noted that to obtain Fig. 24, we need most of
the new developments of the model, which therefore appear to be important in order to describe
reality: the mechanical specificity related to the duct, the pressure influence on proliferation and
its correction, the forced diffusion of nutrients within the duct to simulate the avascular stage,
the multi-cell simulation and the microenvironment role in MMP production. In particular, this
result seems to support the idea that microenvironmental factors play a crucial role in tumor
progression, in agreement with many recent studies in oncology [6, 26, 31].
Despite the satisfactory behavior of the model, we can highlight some points for further study.
The use of Darcy law, at the heart of the model, raises issues that indicate some limits of the
model. First, when the tumor grows and fills the duct, it may tend to deform the duct membrane,
implying a feedback on the rate of tumor growth due to the membrane elasticity. To take the
membrane elasticity into account, we could use a Stokes law [3, 32] rather than Darcy law, which
would significantly complexify the model. Secondly, carcinoma in situ may have very different
architectures from one cancer to another. The model provides only two of the main types of
breast carcinomas: solid and comedo carcinomas. Other types of breast intraductal carcinoma
mentioned in the medical literature are:
• the micropapillary carcinoma develops along the epithelium, with tumor cells projections
towards the center of the duct, without filling (Fig. 27a)
• the papillary carcinoma develops inside the duct with irregular shapes (Fig. 27b)
• the cribriform carcinoma is caracterized by distinctive holes between the cancer cells
(Fig. 27c).
(a) micropapillary (b) papillary (c) cribriform
Figure 27: Other types of intraductal carcinoma. Taken from [21].
These other types of carcinomas are more difficult to model: in each case (Fig. 27), projections
and spans of tumor cells appear to indicate that some of adhesion and polarity properties have
been kept by the cells. In our model, the permeability coefficient, introduced with Darcy law,
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does not distinguish between the different types of adherent junctions. Above all, it simulates
neither the polarization of proliferating cells nor the orientation of cell divisions. Thus, the
continuous model finds its limits when it comes to simulate phenomena that are played at the
cellular level. A discrete model, where each cell is modeled by an agent, like in [33, 34, 35], seems
more appropriate. Note that Norton et al. model those different types of carcinomas at the
stage in situ, in [36]. Coupling the continuous model with a discrete model could be considered
as in [37] to simulate an invasive phase of these types of cancer.
There still remains numerous unanswered questions regarding the biological phenomena that
are involved: the impact of the pressure, or mechanical stress, on tumor growth seems to be
ambiguous [8, 38]. It could even have an impact on genetic mutations and production of MMPs.
The production of MMPs seems even more complex than what we simulated, involving different
kinds of MMPs. The structure and activity of the membrane, here reduced to an interface, could
also be a determining factor in the invasive process [31]. Finally, the migration of specific cells
of the microenvironment (such as immune cells, macrophages, fibroblasts), randomly simulated
in our study, should be further studied in the hope of bringing predictability to the model.
It is worth noting that according to our model, either oncogenic or microenvironmental factors
make possible to obtain heterogeneous tumors, in accordance with biopsies. Our paper can be
seen as a first step in the study of the influence of these factors, and in their modeling in order
to provide realistic tumor shapes.
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